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Dietary inflammatory index as a potential determinant
of a length of hospitalization among surgical patients
treated for colorectal cancer
A Galas1, P Kulig2 and J Kulig2
BACKGROUND/OBJECTIVES: Inflammation is a central process responsible for health outcomes among surgical patients.
Immunonutrition has been investigated as a promising modifying factor; however, inflammatory properties of habitual diet have
not yet been investigated. The purpose of this study was to describe inflammatory properties of diet measured by the dietary
inflammatory index (DII) among surgical patients treated for colorectal cancer and to link inflammatory properties of habitual diet
with a duration of hospitalization.
SUBJECTS/METHODS: A follow-up study among colorectal cancer patients treated surgically was performed in Krakow, Poland.
In total, 689 patients were recruited for the study. Habitual diet was assessed using a standardized semiquantitative food frequency
questionnaire. Overall, 23 dietary items (including macro-and micronutrients) were used to calculate individuals’ DII. Gender, age,
marital status, body mass index, smoking status, lifetime physical activity, taking vitamin supplements, number of chronic diseases,
cancer site, Duke’s staging and surgery type were considered as potential covariates.
RESULTS: Participants were aged 58 years, with the average hospitalization time of 11 days. Higher DII (meaning diet with higher
anti-inflammatory properties) was negatively associated with the duration of hospitalization (univariable linear regression:
b=− 0.59; P= 0.005). Multivariable logistic regression has shown the decrease of the risk of longer stays (47 days) among patients
with the DII 4− 4.25, but only among younger (⩽60 years) patients, irrespective of Duke’s staging.
CONCLUSIONS: The DII might be used as a potential predictor of longer hospitalization among colorectal cancer patients treated
surgically. The study provides evidence for the role of dietary-related low-grade inflammation among surgical patients.
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INTRODUCTION
It has been observed that inflammation is one of the important
properties of several diseases. First, inflammation may be an
image of the presence of acute injury or damage to tissue. Second,
during the past decades, an increasing interest in inflammation as
an underlying factor responsible for the development of the
disease has been observed.1 There are several inflammatory
biomarkers, such as, interleukin-1β (IL-1β), IL-4, IL-6, IL-10, tumor
necrosis factor-α and C-reactive protein (CRP), involved in the
process, and their increased concentration is an effect of the
nonspecific immune response. In some disorders, inflammatory
process, which under normal conditions is self-limiting, becomes
continuous and chronic—being the underlying cause of chronic
inflammatory diseases.2 Increased levels of CRP and some other
inflammatory cytokines have been noticed as risk factors for lung
cancer3 and colon cancer.4 Additionally, more specific high-
sensitivity CRP has been observed and linked with the develop-
ment of atherosclerosis, and a number of cardiovascular disease
end points.5,6 Some proinflammatory cytokines, such as IL-6 and
tumor necrosis factor-α, have also been associated with obesity
and insulin resistance.7
Nowadays, there is an increasing evidence linking diet with
inflammation. Dietary patterns have been investigated as one of
the key components in the regulation of chronic inflammation.8
It has been discovered that the Western-type diet is associated
with higher levels of inflammatory cytokines,9 whereas that of
the Mediterranean diet with lower levels.10,11 The same has
been noticed for some other dietary items and nutrients, such as
fruits and vegetables, polyunsaturated fatty acids and
vitamins.12–14
It should be mentioned that diet also has a key role in
immunonutrition (meaning the effects of nutrients—including
macronutrients, vitamins, minerals and trace elements—on
inflammation, providing a means of modulating the inflammatory
response to injury and infection, and thus improves clinical
outcome). There is an increasing body of evidence showing a
beneficial effect of modified diets (rich in vitamins C and E,
arginine, glutamine, nucleotides and n-3 fatty acids), especially
among critically ill patients in terms of surgical outcomes in both
malnourished and well-nourished patients.15,16
All these observations suggest the need to create a system to
score and assess general inflammatory properties of diet,
considering both the role of pro- and anti-inflammatory dietary
items. Therefore, Cavicchia et al.17 created the dietary inflam-
matory index (DII). As described by its authors, the DII was the
first literature-based index to focus primarily on the inflamma-
tory properties of diet. The benefit of the index is that it assesses
diet as a whole and thus it seems to preponderate other
scores as the alternate healthy eating index or the
alternate Mediterranean diet index. Moreover, the DII is not
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dependent on the population means or on the recommenda-
tions of intake, and it is not only limited to macronutrients and
micronutrients but also incorporates commonly consumed
components of the diet, including spices, tea and others.17
Inflammation is a central process observed in surgical patients
and is a key component—after underlying disease and general
health condition, accompanying wound healing18 and respon-
sible for the time of recovery.19 Modifying factors associated
with inflammatory properties may have a role in surgical
outcomes; therefore, considering diet as one of the determi-
nants of low-grade inflammation possibly associated with
individual’s vulnerability to develop health-related outcomes,
we decided to test the effect of habitual diet among surgically
treated patients.
PURPOSE
The purpose of the study was to describe inflammatory properties
of diet measured by the dietary inflammatory index (DII)
developed by Cavecchia et al.17 among surgical patients treated
for colorectal cancer and to link inflammatory properties of
habitual diet with a short-term surgical outcome as a duration of
hospitalization in this group of patients.
MATERIALS AND METHODS
Study design and sample
A follow-up study was performed among patients admitted to the I Chair
of General Surgery and Department of Gastroenterological Surgery,
Jagiellonian University Medical College, Krakow, Poland to be treated for
colorectal cancer. Patients eligible for the study were cases recruited for a
case–control study conducted between 2000 and 2013. The study design
of a primary research has been described elsewhere.20,21 In brief,
participants were newly diagnosed incident cases of sporadic adeno-
carcinomas either of the colon or rectum. Inclusion criteria were as
follows: age of up to 75 years, Caucasian, being a native Polish and
referred for a surgical treatment of colorectal cancer. Exclusion criteria
were as follows: presence of communication (verbal contact) problems
and/or cognitive limitations, and diagnosis of any of the following:
hereditary non-polyposis colorectal cancer, familiar adenomatous poly-
posis, attenuated familial adenomatous polyposis, mixed polyposis
syndrome, Ashkenazi colon cancer, hereditary breast and colorectal
cancer or any of hamartomatous polyposis syndrome, and also diagnosis
of secondary cancer (its distant metastasis in large bowel), diagnosis of
primary cancer other than colorectal, recurrent cancer, underwent
surgery (before recruitment) of gastrointestinal tract, present or past
diagnosis of chronic disease of gastrointestinal tract (diverticulitis,
irritable bowel syndrome, acute or chronic gastric ulcer, acute or chronic
pancreatitis), diabetes (any type), renal failure, hepatic insufficiency or the
presence of prolonged gastrointestinal symptoms. The diagnosis of either
colon cancer or rectal cancer in all study participants was confirmed
histopathologically.
Tools and data collection
Study participants were interviewed, after the admission to the hospital
but before surgery, about their dietary habits, lifetime recreational
physical activity, some demographic characteristics (age, gender, marital
status, etc.), presence of medical diagnosis and/or being treated for
chronic conditions and some other potential covariates. Dietary habits
were assessed by a semiquantitative food frequency questionnaire
(SFFQ) developed in cooperation with the German Cancer Research
Centre in Potsdam, where an introductory part of the European
Prospective Investigation into Cancer and Nutrition (EPIC-Potsdam)
project had been performed. In total, 148 dietary items were used,
including questions about consumption of cereals, dairy products, bread,
type and cuts of meat and fish (including preparation technique), fresh
fruits (summer and winter time), salads and fresh and cooked
vegetables, rice or pasta, soups, sweets, baked goods, drinks and others.
For each food or beverage item, a commonly consumed portion size was
specified by standardized photographs. Next, respondents were asked to
provide information about frequency of consumption. For the research,
information about usual (habitual) consumption over the period of 1
year by calendar seasons was gathered by trained interviewers. Patient-
cases were asked about their dietary patterns at a time of 5 years before
the onset of gastrointestinal symptoms (if present) or before the
beginning of the diagnosis process. Next, dietary data were recalculated
using Polish food composition tables to obtain information about an
average consumption of dietary macro- and micronutrients.22,23 The
validity and reproducibility of the questionnaire was assessed and
published elsewhere.24,25
Inflammatory properties of diet have been assessed by the DII
developed by Cavicchia et al.17 The DII considers different nutritional
data including caloric intake, consumption of different beverages and
alcoholic drinks and intake of macro- and micronutrients such as
vitamins, microelements and others. Dietary data collected in the current
investigation allow calculation of the following: an average intake of
energy, drinking of tea, consumption of caffeine, different alcoholic
drinks such as wine, beer and liquor (for the purpose of the study, the
consumption of wine and beer was considered directly, and other
sources of alcohol such as as fruit wine, sparking wine and vodka were
recalculated according to their content of pure alcohol, and thus they
were used in the calculation of the DII), an intake of carbohydrates, fiber,
fat, n-3 and n-6 fatty acids, monounsaturated fatty acids, saturated fatty
acids, protein, cholesterol, vitamin A, thiamin, riboflavin, niacin, vitamin C,
vitamin E, β-carotene and iron. In this study, therefore, it was possible to
obtain the DII based on the 23 different dietary items. The DII measure
was calculated as a sum of adjusted scores as they were published by
Cavicchia (see Annex). Finally, the DII related to habitual diet was
obtained for every individual.
Length of hospitalization
Information about a length of hospitalization was collected from hospital
registry. The duration of hospitalization was determined as the number of
hospital days after the day of surgery.
Covariates
The following characteristics were considered as potential covariates:
(1) gender; (2) age (continuous); (3) marital status (married, other); (4) body
mass index (o25 kg/m2, ⩾ 25 kg/m2); (5) current smoking status (active
smoker, non-smoker); (6) an average adult lifetime physical activity (as an
average MET-h per day, continuous); (7) taking vitamin supplements
(yes/no); (8) number of chronic diseases (non, 1, 2 or more): patients were
questioned if they had been diagnosed with myocardial infarction, angina
pectoris, stroke, an episode of ischemia of central nervous system,
hypertension, diabetes, hyperlipidaemia or cholelithiasis; (9) cancer site
(colon, rectum); (10) Duke’s staging; (11) surgery type (radical, palliative).
Statistical analysis
As a first step of investigation, the DII for every individual was calculated as
described above. A linear regression was used to assess an association
between DII and the length of hospitalization. This analysis was performed
for the whole sample and also after exclusion of individuals who might be
outliers, meaning that these with the values below 5th percentile or over
95th percentile of the DII distribution were excluded.
Next, two groups were created depending on a length of hospitalization.
The cutoff value was decided primarily on the value of 7 days. This decision
was based considering a typical duration of hospitalization observed
among patients treated surgically on the gastrointestinal surgery ward,
that is, patients without complications who were treated in a standard way.
The main determinants related to the length of hospitalization have been
provided across groups. Characteristics expressed as categorical were
compared across groups by the χ2 test, because every expected count was
higher than 5. Continuous variables were tested by Shapiro–Wilk test to be
normally distributed. The analyses had shown skewed distributions, and
the Mann–Whitney U-test was subsequently used. Finally, different cutoffs
of the DII were tested to assess usefulness of the DII in terms of prediction
of longer (meaning 47 days) duration of hospitalization. The values of the
first tertile, the first quartile and the first quintile of the DII distribution
were considered and analyzed in the multivariable logistic regression
models. The aforementioned covariates, as potentially associated with the
health condition and the duration of hospitalization were used.
The study was conducted in accordance with the ethical principles of
the Declaration of Helsinki and was approved by the Bioethical Committee
of Jagiellonian University (number KBET/115/B/2011).
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RESULTS
In total, during the period 2000–2013, 703 cases were recruited for
the study and interviewed. Overall 14 individuals were excluded
from the analyses owing to the lack of information about lifestyle
factors (not willing to finish an interview), refusals to undergo
surgery treatment, no access to detailed information about
hospitalization or being a patient admitted for reoperation. Finally,
the remaining 689 cases were analyzed.
Basic characteristics of the study sample are presented in
Table 1. Participants were more frequently males, at an average
age of 58 years. They were mainly married (86.5%), overweight or
obese (69.5%), and one-fourth were active smokers. Patients
reported an average adult lifetime physical activity at a level of
17.4 MET-h per day and in total less than 20% reported taking
vitamin supplements. Overall 83% did not report being diagnosed
with other chronic diseases. Considering clinical status, there were
Table 1. Basic characteristic of the study group
Total (n= 689) Hospitalized ⩽ 7 days (n= 274) Hospitalized 47 days (n= 415) P-value
Males (n (%)) 391 (56.7%) 145 (52.9%) 246 (59.3%) d.f.= 1
Pχ= 0.099
Age (years)
Mean (s.d.) 58.0 (8.9) 58.1 (8.9) 57.9 (9.0)
Median, Q1–Q3 59 (52–65) 59 (52–65) 59 (52–65) PMW= 0.967
Marital status (n (%))
Married 596 (86.5%) 232 (84.7%) 364 (87.7%)
Single/widowed/divorced 93 (13.5%) 42 (15.3%) 51 (12.3%) d.f.= 1
Pχ= 0.253
BMI (n (%))
o25 kg/m2 210 (30.5%) 94 (34.4%) 116 (28.0%)
⩾ 25 kg/m2 478 (69.5%) 179 (65.6%) 299 (72.0%) d.f.= 1
Pχ= 0.071
Current smoking (n (%)) 173 (25.1%) 68 (24.8%) 105 (25.3%) d.f.= 1
Pχ= 0.886
Average adult lifetime physical activity (MET-h per day)
Mean (s.d.) 17.4 (16.1) 15.3 (13.5) 18.8 (17.4)
Median, Q1–Q3 13.0 (5.6–24.6) 11.7 (5.7–20.4) 13.8 (5.6–27.0) PMW= 0.039
Taking vitamin supplements (n (%)) 127 (18.4%) 38 (13.9%) 89 (21.5%) d.f.= 1
Pχ= 0.012
Dietary inflammatory index
Mean (s.d.) − 2.66 (2.43) − 2.37 (2.29) − 2.85 (2.51)
Median, Q1–Q3 − 2.42 (−3.91 to − 1.15) − 2.24 (−3.59 to − 1.11) − 2.60 (−4.09 to − 1.19) PMW= 0.020
Chronic diseases (n (%))
Non 572 (83.0%) 235 (85.7%) 337 (81.2%)
1 103 (15.0%) 33 (12.0%) 70 (16.9%)
2+ 14 (2.0%) 6 (2.2%) 8 (1.9%) d.f.= 2
Pχ= 0.219
Cancer site (n (%))
Colon 332 (48.2%) 147 (53.6%) 185 (44.6%)
Rectum 357 (51.8%) 127 (46.4%) 230 (55.4%) d.f.= 1
Pχ= 0.020
Duke’s staging (n (%))
A 45 (6.9%) 30 (11.5%) 15 (3.8%)
B 263 (40.3%) 113 (43.1%) 150 (38.5%)
C 166 (25.5%) 69 (26.3%) 97 (24.9%)
D 178 (27.3%) 50 (19.1%) 128 (32.8%) d.f.= 3
Pχo0.001
Surgery type (n (%))
Radical 628 (91.1%) 259 (94.5%) 369 (88.9%)
Palliative 61 (8.9%) 15 (5.5%) 46 (11.1%) d.f.= 1
Pχ= 0.011
Hospitalization time (days)
Mean (s.d.) 10.9 (9.4) 5.7 (1.3) 14.4 (10.8)
Median, Q1–Q3 8 (6–12) 6 (5–7) 11 (9–15) PMWo0.001
Abbreviations: BMI, body mass index; chi, chi-squared test; MW, Mann–Whitney U-test.
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similar proportions of colon and rectal cancers, patients were
mainly in Duke’s B stage and over 90% of cancers were radically
removed during surgery. The mean hospitalization time was
10.9 days (s.d. = 9.4), with an interquartile range from 6 to 12 days.
As the DII is a new index to measure inflammatory properties of
diet—as a first step of investigation, the relationship between DII
and the time of hospitalization was measured by a simple linear
regression. The analysis considering all available subjects has
shown negative association, but insignificant (b=− 0.27; P= 0.067)
(Figure 1). As linear regression is very sensitive for outliers, the
same regression was performed after exclusion of subjects with
the DII values below 5th or over 95th percentile, and subsequently
the observed negative association was statistically significant
(b=− 0.59; P= 0.005) (Figure 2).
In the second part of the analysis, patients were divided into
two subgroups: those hospitalized no longer than 7 days and
others. Basic characteristics have been compared between these
groups, and differences have been noticed for DII, an average
adult lifetime physical activity, taking vitamin supplements, cancer
location, Duke’s staging and surgery type (Table 1). Next, we
decided to investigate different cutoffs to test the relationship
between the DII and duration of hospitalization in the multi-
variable logistic regression (Table 2). The decrease in the risk was
observed, but results were not significant. A significant effect was
noticed if patients were divided according to the Duke’s staging
considering separately those with local or distant metastases
(Duke’s C or D) and those without (Duke’s A or B), and then
patients with the DII over the first tertile (4− 3.41) or over the first
quartile (4− 3.91) presented significant decrease in the risk of
hospitalization of longer than 7 days. As the last step, differences
in the effect of the DII across different age groups were analyzed.
This decision was driven by some previous results showing
differences in the outcomes related to the age category of
patients.26 The current investigation has shown that younger (⩽60
years) patients presented, consequently, the decrease in the risk
for the cutoff of the first quartile (4− 3.91) and first quintile
(4− 4.25) for both Duke’s subgroups, whereas the effect was not
observed among older patients.
DISCUSSION
The study presents an evidence of the relationship between
inflammatory properties of diet and a short-term clinical outcome
as a duration of hospitalization among surgically treated colorectal
cancer patients. Moreover, it supports a usefulness of the DII in the
prediction of longer (47 days) hospitalization. In the current
investigation, it has been shown in a modern way that habitual
diet associated with inflammatory biomarkers might be an
additional predictor of recovery time among surgical patients.
Although the results suggest a linear relationship between the DII
and the duration of hospitalization, it was decided to test and to
find a cutoff that might be used for predictive purposes. This
decision was also supported by previously published results
showing that the DII, fitted as a categorical variable, was able to
predict some interval changes in CRP.17 Additionally, the knowl-
edge of the cutoffs may be useful for both clinical purposes to
define patients being at higher risk and for research, as the results
suggest the importance of the inflammatory properties of
habitual diet.
The role of inflammation among surgical patients was tested in
several ways. It was found that inflammation which complicates
the course of a clinical treatment is one of the key component of
hospital morbidity and mortality.27–30 It was observed that within
hours of physical injury, large number of arginase-1 (ARG1)
expressing immature myeloid cells accumulate in the spleen and
other lymphoid tissue.31 These cells (also called myeloid-derived
suppressor cells) inhibit T-lymphocyte growth and function,
resulting in the impairment of T-cell proliferative response.32
It was found that T helper type 2 cytokines, catecholamines and
prostaglandin E2 induce the expression of myeloid-derived
suppressor cells and act synergistically to increase the expression
of ARG1.33 Thus, the stress response with the release of cortisol
and catecholamines together with the release of prostaglandin
E2 results in further impairment of T-cell proliferative responses.
The preventive aim in this situation is to minimize the
immunosuppression to reduce the risk of secondary infections,
and to promote healing and tissue repair. Recently, increased
attention has been focused on an immunomodulating diet, and
it has been suggested a beneficial effect of pre- and post-
operative immunonutrition,16,34,35 but published results are not
consistent.36,37 Diet as a determinant of low-grade inflammation
seems to be directly associated with the ARG1 pathway.
Prolonged, low-grade inflammation may lead to the lack
of reserves on the subclinical level, and in the case of
surgery, it may be a risk factor for unfavorable outcomes among
patients.
Figure 1. Univariable linear regression between the DII and duration
of hospitalization after surgery among patients treated for colorectal
cancer (whole sample n= 689).
Figure 2. Univariable linear regression between the DII and duration
of hospitalization after surgery among patients treated for colorectal
cancer (after exclusion of subjects with the DII o5th percentile and
with the DII 495th percentile n= 620).
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In our study, it was possible to investigate the role of habitual
diet as a potential predictor of a length of hospitalization. There
are some weaknesses and strengths of our findings. The strength
comes from the possibility to assess the role of habitual diet as a
long-term lifestyle determinant. Several studies have shown that
the presence or the development of different health outcomes is
determined not only by the concurrent clinical factors but also
by the accumulation of ‘good and bad experiences over the
lifetime’.38 This is nowadays the key concept of the life-course
approach in medicine, meaning that our past exposures are
responsible for the outcomes observed in a present day. Thus,
the role of the DII in the duration of hospitalization should be
considered rather as a measure of vulnerability related to the
general condition of the human body—which is also a result of a
prolonged exposure to dietary factors. The role of diet as a
determinant of low-grade inflammation in terms of life-course
approach for clinical outcomes has not been investigated so far.
Other strengths of our study include considering of several
important covariates. The results have been accounted for age
and number of diagnosed chronic diseases—main determinants
of health outcomes. It has been decided to adjust for marital
status as it is a proxy measure of social circumstances, which may
influence some decisions regarding the timing of discharge.
Other important covariates considered were smoking status,
adult lifetime physical activity and, more importantly, clinical
features as cancer site, Duke’s staging and surgery type.
Regarding staging, the results have shown the benefit of ‘better’
(meaning with lower proinflammatory potential, that is, higher
the DII) diet for both Duke’s A to B stage and C to D stage
patients, but only among younger (⩽60 years) patients. This has
not been observed in older patients. Some possible explanations
are that older patients share some additional features related to
the response to the presence of a disease and surgery that may,
more importantly than among younger patients, determine the
duration of hospitalization. In our study, patients at Duke’s A and
B have been investigated together. If they were considered
separately, the odds ratios were 0.53 and 0.52 for the 1st quartile
cutoff (for Duke's A and Duke's B, respectively), and 0.49 and 0.42
for the 1st quintile cutoff; however, these results (although
similar to the results observed for the whole A plus B group)
were not statistically significant owing to a decrease in
sample size.
The study has also some limitations, as we investigated only 23
dietary items for the calculation of the DII. Although there are
much more of them—those included in the analyses are the
main constituents responsible for the effect of diet in the Polish
population. In that study, there were no information about herbs
available, but the use of herbs in the Polish population was
rather rare in previous years, and it has become more popular
over the past few years and more typically among younger
population; therefore, the distorting effect of herbs, even though
possible, was rather unlikely. In general, only patients with good
health condition were referred to surgery, but there was still a
possibility that some of them had additional (not considered in
the analyses) factors associated with longer hospitalization. We
had only a possibility to assess a duration of hospitalization as an
outcome measure in the study. There are published papers
showing the relationship between inflammatory status and some
other outcomes as number of infectious complications or
long-term survival.27,34,35 Although the data regarding the
number of infectious complications and their severity were not
available, the duration of hospitalization is also a very good
proxy measure for these outcomes, because the development of
any complication increases the duration of onward stay. The
weakness is also the fact that inflammatory status of the patient
is determined by much more factors other than diet, and,
although the results have been adjusted for several covariates,
there is still a possibility to have a residual confounder. The
participants of our research had no measurements of serum
inflammatory cytokines. The only inflammatory biomarker
available for some of the study subject was the leukocyte count.
To check weather inflammatory status at the admission to
surgical ward was responsible for a longer hospitalization in our
research, we compared shorter (⩽7 days) and longer (47 days)
hospitalization group, and we did not observe any statistically
significant difference (white blood cells: 8.2 × 103/ml vs
7.1 × 103/ml in groups, respectively, P= 0.312).
In summary, the investigation of inflammatory properties of diet
using the DII as a predictor of some clinical outcomes is novel to
our knowledge, as there are no published papers to date, and it
provides a quite new insight in the role of diet. The results of the
current research have shown the usefulness of the DII developed
by Cavicchia as a potential predictor of longer hospitalization
among patients treated surgically for colorectal cancer. Moreover,
by more complex assessment of the role of diet considering its
inflammatory properties, the study provides evidence for the role
of dietary habits among surgically treated patients.
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Table 2. ORs of prolonged hospitalization (47 days) in different
Duke’s staging groups
DII Total ORs (95% CI) Duke’s A or B Duke’s C or D
All agesa
⩽− 3.411 1b 1b 1b
4− 3.41 0.76 (0.53–1.09) 0.66 (0.44–0.996) 0.79 (0.38–1.66)
⩽− 3.912 1b 1b 1b
4− 3.91 0.69 (0.46–1.03) 0.63 (0.40–0.99) 0.56 (0.24–1.32)
⩽− 4.253 1b 1b 1b
4− 4.25 0.69 (0.45–1.07) 0.64 (0.39–1.03) 0.53 (0.21–1.38)
⩽ 60
⩽− 3.411 1b 1b 1b
4− 3.41 0.68 (0.43–1.08) 0.69 (0.40–1.19) 0.51 (0.21–1.28)
⩽− 3.912 1b 1b 1b
4− 3.91 0.46 (0.27–0.78) 0.51 (0.28–0.93) 0.23 (0.07–0.75)
⩽− 4.253 1b 1b 1b
4− 4.25 0.43 (0.24–0.77) 0.44 (0.23–0.85) 0.26 (0.07–0.97)
460
⩽− 3.411 1b 1b 1b
4− 3.41 0.88 (0.49–1.60) 0.62 (0.33–1.17) 2.59 (0.48–13.90)
⩽− 3.912 1b 1b 1b
4− 3.91 1.25 (0.66–2.37) 0.83 (0.42–1.63) 4.73 (0.81–27.45)
⩽− 4.253 1b 1b 1b
4−4.25 1.44 (0.72–2.92) 1.09 (0.51–2.31) 3.11 (0.52–18.62)
Abbreviations: CI, confidence interval; OR, odds ratio. aAdjusted for gender,
age (years), total number of chronic diseases (non, 1, 2+), current smoking
status (smoker, non-smoker), surgery type (palliative/radical), cancer site
(colon/rectum), taking vitamin supplements (yes/no), level of adult lifetime
physical activity (MET-h per day), overweight or obesity (yes/no) and
marital status (currently married, other). bReference group: 1, first tertile;
2, first quartile; 3, first quintile.
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